18F-FDG PET/CT在多发性骨髓瘤中的应用：关键见解与未来方向 - Suppr

F-FDG PET/CT in multiple myeloma: critical insights and future directions.

作者信息

Bailly Clément, Carlier Thomas, Jamet Bastien, Touzeau Cyrille, Moreau Philippe, Kraeber-Bodéré Françoise, Bodet-Milin Caroline

机构信息

CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France.

Department of Nuclear Medicine, CHU de Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France.

出版信息

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1048-1050. doi: 10.1007/s00259-019-04279-7. Epub 2019 Feb 15.

DOI:10.1007/s00259-019-04279-7

PMID:30770949

Abstract

摘要

相似文献

F-FDG PET/CT in multiple myeloma: critical insights and future directions.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1048-1050. doi: 10.1007/s00259-019-04279-7. Epub 2019 Feb 15.

Prognostic value of [F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1694-1704. doi: 10.1007/s00259-018-3997-0. Epub 2018 Apr 2.

Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):116-128. doi: 10.1007/s00259-018-4108-y. Epub 2018 Jul 27.

Dual assessment with multiparameter flow cytometry and F-FDG PET/CT scan provides enhanced prediction of measurable residual disease after autologous haemopoietic stem cell transplant in myeloma-a prospective study.

Bone Marrow Transplant. 2023 Sep;58(9):1045-1047. doi: 10.1038/s41409-023-02017-0. Epub 2023 Jun 16.

Treatment response evaluation with F-FDG PET/CT and F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation.

Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):50-62. doi: 10.1007/s00259-016-3502-6. Epub 2016 Aug 29.

The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1068-73. doi: 10.1016/j.bbmt.2015.03.001. Epub 2015 Mar 6.

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.

Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.

PET Clin. 2019 Jul;14(3):383-389. doi: 10.1016/j.cpet.2019.03.005. Epub 2019 Apr 19.

[Prognostic value of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients].

Zhonghua Yi Xue Za Zhi. 2019 Jan 22;99(4):301-306. doi: 10.3760/cma.j.issn.0376-2491.2019.04.013.

Role of F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4.

引用本文的文献

The ratio of brain to liver glucose activity and disease activity in multiple myeloma.

Blood Cancer J. 2025 May 7;15(1):90. doi: 10.1038/s41408-025-01280-2.

A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

Clin Cancer Res. 2023 Apr 14;29(8):1429-1439. doi: 10.1158/1078-0432.CCR-22-2263.

本文引用的文献

Utility and prognostic value of F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma.

Am J Hematol. 2018 Dec;93(12):1518-1523. doi: 10.1002/ajh.25279. Epub 2018 Oct 2.

F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):107-115. doi: 10.1007/s00259-018-4114-0. Epub 2018 Sep 5.

Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study.

Clin Cancer Res. 2018 Nov 1;24(21):5219-5224. doi: 10.1158/1078-0432.CCR-18-0741. Epub 2018 Aug 1.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):116-128. doi: 10.1007/s00259-018-4108-y. Epub 2018 Jul 27.

Prognostic value of [F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation.

Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1694-1704. doi: 10.1007/s00259-018-3997-0. Epub 2018 Apr 2.

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nat Commun. 2017 Aug 16;8(1):268. doi: 10.1038/s41467-017-00296-y.

Prospective Evaluation of Magnetic Resonance Imaging and [F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.

J Clin Oncol. 2017 Sep 1;35(25):2911-2918. doi: 10.1200/JCO.2017.72.2975. Epub 2017 Jul 7.

Role of F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.

Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4.

Report of the 6th International Workshop on PET in lymphoma.

Leuk Lymphoma. 2017 Oct;58(10):2298-2303. doi: 10.1080/10428194.2017.1298752. Epub 2017 Mar 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

F-FDG PET/CT in multiple myeloma: critical insights and future directions.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献